Medical News
The Value of Ollin Biosciences’ Playbook: Capturing Early Innovation Before the Geographic Shift
The deal announced on November 16—in which Johnson & Johnson agreed to acquire Ollin Biosciences...

Tag
The deal announced on November 16—in which Johnson & Johnson agreed to acquire Ollin Biosciences...

Eli Lilly and NVIDIA have partnered to launch the largest AI-powered supercomputing platform in pharma, aiming to accelerate drug discovery, personalize medicine, and enhance manufacturing through unprecedented computational power.
